LONDON, February 7 /PRNewswire/ -- Misys (FTSE: MSY.L), the global application software and services company, today announces that the OJSC Bank VTB, the second largest bank in Russia with the biggest share of trade finance business in Financing Russian Exports/Imports in 2006 under EBRD Trade Facilitation Program, has successfully gone live with its award-winning trade finance system, Misys Trade Innovation. As a result of this, the bank is expecting to see an increased performance in its trade finance operations and thus deliver more results to its customers.

STOCKHOLM, Sweden, February 7 /PRNewswire/ --

- General availability of first announced software-based multi-party HD-video conferencing solution; enables delivery of affordable HD-video conferencing

Global IP Solutions (GIPS), the leading provider of media processing solutions, today announced the general availability of its High-Definition (HD) enabled video conferencing engines for service providers, developers, manufacturers and enterprises.

GIPS' new offering enables organizations to deliver software-based multi-party HD video conferencing. The software-based approach significantly reduces the cost of High Definition video conferencing, making it ideal for consumers or desk-top use in business.

PLEASANTON, California, February 7 /PRNewswire/ --

- The first ever on-demand, hands-on training program for the server virtualization industry is launched by Citrix to train its worldwide channel partners.

Toolwire, a leading innovator of experiential distance learning solutions announces their agreement with Citrix Systems, Inc. to develop and deliver an on-demand lab environment to train Citrix worldwide channel partners.

TOKYO, February 7 /PRNewswire/ --

ACCESS CO., LTD., a global provider of advanced software technologies to the mobile and beyond-PC markets, today announced that worldwide deployments of its NetFront(TM) products, notably NetFront(TM) Browser for mobile handsets and information appliances, surpassed 500 million at the end of January, 2008.

PRINCETON, New Jersey and UXBRIDGE, England, February 7 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced results from the CASTLE study, in which 300 mg of once-daily REYATAZ(R) (atazanavir sulfate) taken with 100 mg of ritonavir (REYATAZ/r) showed similar antiviral efficacy to twice-daily lopinavir 400 mg and ritonavir 100 mg (lopinavir/r) in previously untreated adult HIV-1 infected patients at 48 weeks, as part of HIV combination therapy. In this study, 78 percent of the 440 patients in the REYATAZ/r arm met the primary endpoint of achieving undetectable viral load (defined as HIV-1 RNA less than 50 copies/mL) at 48 weeks, compared with 76 percent of the 443 patients in the lopinavir/r arm.

JENA, Germany, February 7 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of coronary occlusion devices today announced that it has obtained approval for its IP position in relation to patents held by AGA Medical Inc. from AIPPI, the European International Association for the Protection of Intellectual Property.

AIPPI is the world's leading non-government organization for research into and protection of intellectual property, and is a respected source for opinions and arbitration on IP matters such as patent interpretation and the use of IP in unfair competition.